Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPO
Status:
Not yet recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
comparing the outcome of low-intensity shock wave therapy (Li-SWT) versus solifenacin on
persistent storage symptoms after transurethral surgery for benign prostatic obstruction
(BPO)